-
Mashup Score: 0
Implementing rapid near patient testing (NPT) reduced patient isolation time, length of hospital stay, antibiotic usage, and overall cost.
Source: OncLiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection (CDI) from a live symposium at DDW 2022.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
🖥️ Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection from a live symposium at DDW 2022. #MedEd #CME #MedTwitter #pediatrician #CDI 📍 https://t.co/Z1vI3jx7Ic https://t.co/hytjG9GbN1
-
-
Mashup Score: 0
Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection (CDI) from a live symposium at DDW 2022.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
🖥️ Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection from a live symposium at DDW 2022. #MedEd #CME #MedTwitter #pediatrician #CDI 📍 https://t.co/G02dERMii6 https://t.co/MHeaGiWG1u
-
-
Mashup Score: 0
Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides difficile infection (CDI) from a live symposium at DDW 2022.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
🖥️ Three experts discuss emerging microbiome-directed treatments for recurrent Clostridioides #difficile infection from a live symposium at DDW 2022. #CDI #MedEd #CME #MedTwitter #pediatrician 📍 https://t.co/QN8aXUAFL5 https://t.co/LKRRwWGzci
-
-
Mashup Score: 0An Exciting Time in CDI: Approvals, Approaches and Anticipation - 1 year(s) ago
The therapies for Clostridioides difficile infection (CDI) saw many developments in recent months and there are more exciting things to come.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The therapies for Clostridioides difficile infection #CDI saw many developments in recent months and there are more exciting things to come. #IDTwitter #MedTwitter https://t.co/84dHQTR3np
-
-
Mashup Score: 0Fidaxomicin, Vancomycin, or Metronidazole? Comparing C Difficile Treatment Cost-Efficacy - 1 year(s) ago
Though the drug is initially more expensive, treating C diff infection with fidaxomicin reduced costs overall by reducing CDI recurrences.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The targeted C difficile treatment fidaxomicin is initially more expensive than other antibiotics, like vancomycin and metronidazole. However, it may save costs in the long run by reducing #CDI recurrences. https://t.co/j8j3sYl0Q6
-
-
Mashup Score: 0CDI Biotherapeutic RBX2660 Outperforms Placebo in Phase 3 Trial - 2 year(s) ago
The closely watched therapeutic candidate led to long-term responses in 90% of patients who benefited from the therapy.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
In a new study, 70.6% of people receiving the recurrent #CDI therapy RBX2660 experienced treatment success at 8 weeks. #IDTwitter https://t.co/nD6Gq3TGVy
-
-
Mashup Score: 0Developing a System to Distinguish C Diff Colonization from Infection Within a Health System - 2 year(s) ago
Northwestern Medicine developed a testing strategy using a two-step algorithm to improve diagnostic accuracy and treatment outcomes.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
.@RadhikaIdpharmd discussed how @NorthwesternMed developed a #CDI testing strategy using a two-step algorithm to improve diagnostic accuracy and treatment outcomes. https://t.co/ncDxjSwIB3
-
-
Mashup Score: 0
Clostridioides difficile infection (CDI) is associated with a range of outcomes, and existing prediction models for death among patients with CDI are imprecise. Peripheral eosinopenia has been proposed as a novel risk factor for death among patients with CDI but has not been incorporated into prediction models. This study aimed to develop and validate a prediction model for death among patients…
Source: Gastro Hep AdvancesCategories: Gastroenterology, Latest HeadlinesTweet-
Prediction model incorporating peripheral eosinopenia developed to improve care for hospitalized patients with #CDI https://t.co/dN4aBKu0F5 https://t.co/3cbzrjrVFV
-
-
Mashup Score: 0Can We Break the Cycle of Recurrent CDI? - 2 year(s) ago
There is an evolution of thinking about how this is treated and investigational therapies are looking to help these patients improve not only their medical conditions but give them back their quality-of-life.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
There is an evolution of thinking about how recurrent #CDI is treated. Investigational therapies are looking to improve not only patients' medical conditions but give them back their quality-of-life. @DrPaulGastro offers his insights on this at #IDWeek2022 https://t.co/3OxOCgO5Sc
-
Implementing rapid near patient testing (NPT) reduced patient isolation time, length of hospital stay, antibiotic usage, and overall cost. #cdiff #CDI https://t.co/SlRyv7h51G